BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1889021)

  • 21. Cefsulodin concentrations in rabbit eyes after intravenous and subconjunctival administration.
    Mester U; Krasemann C; Werner H
    Ophthalmic Res; 1982; 14(2):129-34. PubMed ID: 7088497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection.
    Lee TW; Robinson JR
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):565-72. PubMed ID: 11777180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of the antineoplastic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the aqueous and vitreous of rabbit.
    Ueno N; Refojo MF; Liu LH
    Invest Ophthalmol Vis Sci; 1982 Aug; 23(2):199-208. PubMed ID: 7096015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular concentrations of mitomycin C after extraocular application in rabbits.
    Mietz H; Rump AF; Theisohn M; Klaus W; Diestelhorst M; Krieglstein GK
    J Ocul Pharmacol Ther; 1995; 11(1):49-55. PubMed ID: 8535957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive ocular and systemic pharmacokinetics of dexamethasone after subconjunctival and intravenous injections in rabbits.
    Valtari A; Posio S; Toropainen E; Balla A; Puranen J; Sadeghi A; Ruponen M; Ranta VP; Vellonen KS; Urtti A; Amo EMD
    Eur J Pharm Biopharm; 2024 May; 198():114260. PubMed ID: 38484852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin concentration in the rabbit aqueous humor and vitreous following intravenous and subconjunctival administration.
    Behrens-Baumann W; Martell J
    Infection; 1988; 16(1):54-7. PubMed ID: 3360498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular penetration of chloramphenicol. Effects of route of administration.
    George FJ; Hanna C
    Arch Ophthalmol; 1977 May; 95(5):879-82. PubMed ID: 558746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of intravenously administered tigecycline in eye compartments: an experimental study.
    Ozcimen M; Sakarya Y; Ozcimen S; Goktas S; Sakarya R; Alpfidan I; Erdogan E
    Graefes Arch Clin Exp Ophthalmol; 2014 Dec; 252(12):1993-7. PubMed ID: 25150050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-course of aspirin and salicylate in ocular tissues of rabbits.
    Valeri P; Romanelli L; Martinelli B; Guglielmotti A; Catanese B
    Lens Eye Toxic Res; 1989; 6(3):465-75. PubMed ID: 2486939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular tissue absorption of clindamycin phosphate.
    Tabbara KF; O'Connor GR
    Arch Ophthalmol; 1975 Nov; 93(11):1180-5. PubMed ID: 1191404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of verapamil and norverapamil in the eye and systemic circulation after topical administration of verapamil in rabbits.
    Siegner SW; Giovanoni RL; Erickson KA; Netland PA
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):159-68. PubMed ID: 9572542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.
    Buitrago E; Höcht C; Chantada G; Fandiño A; Navo E; Abramson DH; Schaiquevich P; Bramuglia GF
    Exp Eye Res; 2010 Jul; 91(1):9-14. PubMed ID: 20307538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraocular tissue plasminogen activator concentrations after subconjunctival delivery.
    Lim JI; Maguire AM; John G; Mohler MA; Fiscella RG
    Ophthalmology; 1993 Mar; 100(3):373-6. PubMed ID: 8460008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.
    Weijtens O; Feron EJ; Schoemaker RC; Cohen AF; Lentjes EG; Romijn FP; van Meurs JC
    Am J Ophthalmol; 1999 Aug; 128(2):192-7. PubMed ID: 10458175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular pharmacokinetics of rufloxacin a new fluoroquinolone antibiotic.
    Nucci P; Lombardo N; Cremonesi F; Manitto MP; Brancato R; Ghione M
    Clin Ter; 1992 Jun; 140(6):563-7. PubMed ID: 1322259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental investigations concerning a topical application of sisomicin in the eye (author's transl)].
    Mester U; Krasemann C; Stein HJ
    Klin Monbl Augenheilkd; 1978 Sep; 173(3):359-63. PubMed ID: 750709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of subconjunctivally injected drugs in the anterior segment of rabbit eyes].
    Yamada N; Hiraki S
    Nippon Ganka Gakkai Zasshi; 1995 Mar; 99(3):262-70. PubMed ID: 7732915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetrability of interleukin-1beta and its effect on the concentration of tumor necrosis factor-alpha and interleukin-6 in the aqueous humor of rabbits treated with interleukin-1beta.
    Peng XY; Chen FH; Wang NL; Ma JM; Lee PY; Liu KG; Podos SM
    Chin Med J (Engl); 2009 Sep; 122(18):2165-8. PubMed ID: 19781304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
    Sigurdsson HH; Konráethsdóttir F; Loftsson T; Stefánsson E
    Acta Ophthalmol Scand; 2007 Sep; 85(6):598-602. PubMed ID: 17645424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.